Sealbond Ltd
Sealbond Ltd, DIR, reported a transaction classified as grant at Dogwood Therapeutics, Inc. involving 4098360.000000 shares for an estimated $4999999.20. Reported holdings after the transaction were 25920693.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 26, 2026
- Filing date
- Oct 27, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
DWTX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001104659-26-119154 Common Stock
- Transaction date
- Oct 26, 2026 Filed Oct 27, 2026, 08:05 PM · 1d delay
- Shares
- 4,098,360 sh $1.22 per share
- Estimated value
- $4.99M Computed from shares × price
- Holdings after
- 25,920,693 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Shares acquired in a private placement pursuant to a Subscription Agreement dated October 19, 2026 by and between the Issuer and Sealbond Limited.
- F2
Sealbond Limited, a British Virgin Islands limited company ("Sealbond"), is a wholly-owned subsidiary of Kamfull Limited, a British Virgin Islands limited company ("Kamfull"). Kamfull is a wholly owne…
- F3
Shares are held directly by Conjoint Inc., a Delaware corporation ("Conjoint"). Conjoint is a wholly owned subsidiary of Honglad Limited, a British Virgin Islands limited company ("Honglad"). Honglad…
0 other transactions
0 recent txs